Table 1.
Characteristics of creatinine-based equations identified by the systematic review according to year of publication
Equation | Development Population | Reference Test | Index Test | Validation Cohort |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | N | Mean Age (y) |
Population | Transplant Recipients Included |
Clearance | Filtration marker |
Scaled to BSA |
Multiple measurements |
Mean GFR |
Cr assay | SR M |
Cr in Steady State |
Age Variable |
Sex Variable |
Race Variable |
||
Edwards 14 | 1959 | 44 | U | OP/IP | N | U | Cr | Y | Y | ? | PK | N | B | N | Y | N | N |
Cockcroft-Gault15 | 1974 | 249 | 55 | OP | N | U | Cr | N | Y | 55* | PK | N | Y | Y | Y | N | Y |
Rowe 16 | 1976 | 548 | U | OP | N | U | Cr | Y | N | 79* | PK | N | Y | Y | N | N | Y |
Mogensen17 | 1980 | 9 | U | ? | ? | U | Iothal | ? | ? | ? | PK | N | ? | N | N | N | ? |
Taylor 18 | 1982 | 169 | U | OP/IP | N | P | Cr | Y | N | 69 | PU | N | ? | Y | N | N | N |
Gates 19 | 1985 | 90 | 56 | IP | B | U | Cr | Y | Y | 37 | ? | N | Y | Y | Y | N | Y |
Kaji 20 | 1990 | 18 | 55 | ? | N | U | Cr | N | N | 32* | PK | N | Y | N | N | N | Y |
Robinson 21 | 1990 | 106 | U | IP | N | U | Cr | N | Y | 102* | PU | N | N | Y | Y | N | Y |
Walser 22 | 1993 | 85 | U | IP | N | U | DTPA | O | Y | 13† | PK | N | Y | Y | Y | N | N |
Nankivell-SPK23 | 1995 | 33 | 42 | OP | E | P | DTPA | N | Y | 55* | PK | N | Y | Y | Y | N | Y |
Nankivell 24 | 1995 | 146 | 43 | OP/IP | E | P | DTPA | N | Y | 52* | PU | N | B | N | Y | N | Y |
AASK-pilot 25 | 1996 | 193 | 53 | OP | N | U | Iothal | Y | ? | 69 | PK | N | Y | Y | Y | N | N |
Baracskay 26 | 1997 | 41 | 73 | OP | N | P | Iothal | N | N | 71* | ? | N | Y | Y | N | N | N |
Martin 27 | 1998 | 80 | 62 | ? | N | P | EDTA | N | N | 66* | EN | N | ? | N | Y | N | Y |
MDRD Study 5,28 | 1999 | 1070 | 51 | OP | N | U | Iothal | Y | N | 40 | PK | Y | Y | Y | Y | Y | Y |
Yukawa 29 | 1999 | 179 | 60 | IP | N | U | Cr | N | Y | 44* | PK | N | ? | Y | N | N | N |
AASK-main 30 | 2001 | 1703 | 54 | IP | N | U | Iothal | Y | N | 57 | PK | N | Y | Y | Y | N | N |
Wright 31 | 2001 | 62 | 58 | IP | N | U | EDTA | N | N | 73* | EN | N | N | Y | Y | N | Y |
Mayo32 | 2004 | 900 | 45 | OP | B | U | Iothal | Y | N | 82 | PK | N | Y | Y | Y | N | N |
Virga 33 | 2005 | 530 | 57 | ? | N | U | Cr | N | N | 55* | PK | N | Y | Y | Y | N | Y |
Nix-HPLC 34 | 2006 | 27 | 51 | OP | N | U | Cr | N | N | 71* | HPLC | Y | Y | N | Y | N | N |
Nix-J 34 | 2006 | 27 | 51 | OP | N | U | Cr | N | N | 71* | PK | N | Y | N | Y | N | N |
CHUQ 35 | 2008 | 773 | 54 | OP/IP | N | U | Cr | Y | N | 67 | PK | N | B | Y | Y | N | Y |
CKD-EPI 8 | 2009 | 5504 | 47 | OP | B | U | Iothal | Y | N | 68 | EN | Y | Y | Y | Y | Y | Y |
Matsuo 36 | 2009 | 413 | 51 | IP | ? | U | Inulin | Y | N | 59 | EN | Y | B | Y | Y | N | Y |
BIS-137 | 2012 | 570 | 78 | OP | N | P | Iohex | Y | N | 60 | EN | Y | Y | Y | Y | N | Y |
Note: N=26 equations. Unless otherwise indicated, GFR is expressed in mL/min/1.73 m2.
Abbreviations and definitions: Year; Year of publication, SRM; Traceable to standardized reference material, Y; Yes, N; No, ?; Unknown, B; Both, OP; Outpatient, IP; Inpatient, E; Exclusive, U; Urinary, P; Plasma, Cr; Creatinine, Iothal; Iothalamate, Iohex; Iohexol, DTPA; Diethylenetriaminepentaacetic acid, GFR; glomerular filtration rate, PK; Picrate kinetic, PU; Picrate non-modified, EN; Enzymatic, HPLC; High-performance liquid chromatography; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; BIS, Berlin Initiative Study; CHUQ, Le Centre hospitalier universitaire de Québec; AASK, African American Study of Kidney Disease and Hypertension; SPK, simultaneous pancreas and kidney; BSA, body surface area; SRM, standard reference material; J, Jaffe;
Units are ml/min,
Units are ml/min/3 m2